PPAR Genomics and Pharmacogenomics: Implications for Cardiovascular Disease
The peroxisome proliferator-activated receptors (PPARs) consist of three related transcription factors that serve to regulate a number of cellular processes that are central to cardiovascular health and disease. Numerous pharmacologic studies have assessed the effects of specific PPAR agonists in c...
Saved in:
Main Author: | Sharon Cresci |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2008-01-01
|
Series: | PPAR Research |
Online Access: | http://dx.doi.org/10.1155/2008/374549 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Therapeutic Implications of PPARγ in Cardiovascular Diseases
by: Hiroshi Hasegawa, et al.
Published: (2010-01-01) -
PPAR Agonists and Cardiovascular Disease in Diabetes
by: Anna C. Calkin, et al.
Published: (2008-01-01) -
PPARγ and Its Role in Cardiovascular Diseases
by: Mini Chandra, et al.
Published: (2017-01-01) -
Integrating pharmacogenomics and cheminformatics with diverse disease phenotypes for cell type-guided drug discovery
by: Arda Halu, et al.
Published: (2025-01-01) -
Cyclophosphamide Pharmacogenomic Variation in Cancer Treatment and Its Effect on Bioactivation and Pharmacokinetics
by: Ibrahim El-Serafi, et al.
Published: (2024-01-01)